Marietta, GA (PRWEB) February 14, 2012
In many countries, occupational contact dermatitis ranks first among all notified occupational diseases and constitutes 30% of all occupational diseases . The emerging fiteBac biotech company believes it has the solution for occupations with a high prevalence of contact and irritant dermatitis, also known as chronic eczema. Professions prone to developing hand dermatitis, dry, cracked hands tend to be professions that regularly use mild irritants on a daily basis, such as water (wet work), detergents, cleansing agents, hand cleansers, chemicals, cutting fluids, and abrasives. Occupations affected include, but are not limited to the following: hairdressers, barbers, bakers, pastry cooks, chefs, florists, mechanics, painters and varnishers, tile setters and terrazzo workers, and metal surface workers .
Occupational dermatitis has a significant economic impact on many professions and can be encompassed by social and psychological implications as well. Economically, costs are very high due to the expense of medical care, worker’s compensation, disability payments and indirect costs associated such as lost workdays, loss of productivity and costs of occupational retraining . Socially and psychologically, a study has shown that 38% of people with eczema, or dry hands, noticed interference in their social life . A person's hands can affect outlook and self image. The appearance of an employee’s hands is important in many industries, such as within food service and catering, and could negatively affect the psyche of an employee perceived as having an “odd” skin disease.
"fiteBac Hand Gel is a patent-pending formula that was initially marketed to healthcare industry, but now is also recognized outside the healthcare industry as highly beneficial for those prone to work-related dermatitis," says Kirk Kimmerling DDS. The fiteBac Hand Gel is free of common irritants, such as alcohol, water, and fragrances, and has hydrophobic properties that help to strengthen the skin’s natural moisture barrier, helping to keep hands in good condition and soft without the greasy feeling of other moisturizing gels on the market.
About fiteBac™ SkinCare, LLC, and KHG:
fiteBac SkinCare, LLC, is a subsidiary company of Kimmerling Holdings Group, LLC (“KHG”), a Georgia-based biotech company that has developed an antimicrobial platform intellectual property technology. KHG was founded in 2009 by Kirk Kimmerling, DDS, dentist in Marietta, GA and Dan Kearney. The two set out to create products that would "change the world, one product at a time." Kirk and Dan first targeted bacterial issues in dentistry, knowing that solving those problems would lead to dramatic improvements in oral health and, more importantly, systemic bodily health. They engaged a team of highly accomplished chemists and scientists retired from Fortune 500 companies and researchers from major universities. In doing so, KHG has developed technology with several patents pending that has application well beyond dental materials. Exciting potentials in medical, plastic, composite, coating, and other applications are forthcoming. Additionally, other applications are in various stages of development. fiteBac SkinCare Hand Softening Gel is the first product to be released under the fiteBac brand name. To learn more about fiteBac SkinCare Germicidal Hand Softening Gel, watch our fiteBac SkinCare video.
1. Diepgen, T.L., Kanerva, L. Occupational Skin Diseases. Skin Diseases in Europe. 2005.